Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Omalizumab Co-treatment on Honey-bee Venom Immunotherapy Failure Due to Systemic Reactions

NCT02968394 is registered in ClinicalTrials.gov with The University Clinic of Pulmonary and Allergic Diseases Golnik as lead sponsor.

NCT NCT02968394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02968394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Omalizumab Co-treatment on Honey-bee Venom Immunotherapy Failure Due to Systemic Reactions
Lead sponsor
The University Clinic of Pulmonary and Allergic Diseases Golnik
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2014
Completion date
Not reported
Enrollment
11 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergy, bee venom, immunotherapy, omalizumab